Skip to main content
PharmaCielo Ltd. logo

PharmaCielo Ltd. — Investor Relations & Filings

Ticker · PCLO ISIN · CA71716K1012 LEI · 5493002XOFWMT83TYQ57 TSXV Manufacturing
Open in API
Filings indexed 389 across all filing types
Latest filing 2021-03-16 Capital/Financing Update
Country CA Canada
Listing TSXV PCLO

About PharmaCielo Ltd.

https://www.pharmacielo.com/

PharmaCielo Ltd. is a global supplier specializing in the cultivation, processing, and distribution of medicinal-grade cannabis extracts and dried flower. The company focuses on ethical and sustainable production, aiming to be a leading partner in the global medicinal cannabis market. Utilizing ideal equatorial conditions, PharmaCielo operates large-scale, high-efficiency production facilities, including 12 hectares of open-air greenhouses, enabling four full crops annually for reliable supply. Its product portfolio includes standardized extracts, such as high-purity CBD Isolate, and both psychoactive and non-psychoactive derivatives. Production adheres to pharmaceutical-quality standards, supported by proprietary genetics maintained in a tissue culture lab and advanced processing facilities ensuring consistency and safety.

Recent filings

Filing Released Lang Actions
Amendment to (or amended) preliminary short form prospectus – French.PDF
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus for a securities offering by PharmaCielo Ltd., describing the terms of a new share issuance, including the number of shares, pricing, underwriting arrangements, and regulatory approvals. It includes detailed information about the offering process, legal disclaimers, and subscription conditions. This matches the characteristics of a capital raising document rather than a financial report or announcement. The presence of terms like "placement," "actions offertes," "prix d’offre," and detailed underwriting terms confirms it is a Capital/Financing Update. The document is not an announcement of a report, nor is it a financial statement or earnings release. Therefore, the correct classification is Capital/Financing Update (CAP).
2021-03-16 English
Preliminary short form prospectus – English.pdf
Capital/Financing Update Classification · 100% confidence The document is a preliminary short form prospectus for PharmaCielo Ltd. dated March 15, 2021, describing an offering of common shares. It includes detailed information about the offering price, number of shares, agents' fees, over-allotment options, broker warrants, and regulatory compliance with securities authorities in Canada. The text is typical of a capital raising document that qualifies the distribution of securities to the public. It is not a financial report, earnings release, or management discussion. It is not an announcement of a report but the actual offering document. Therefore, it fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2021-03-16 English
Interim financial statements/report – French.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled "États financiers consolidés intermédiaires résumés pour le trimestre et la période de neuf mois clos le 30 septembre 2020" which translates to "Condensed consolidated interim financial statements for the quarter and nine-month period ended September 30, 2020." It contains detailed financial statements including balance sheets, income statements, cash flow statements, and changes in equity for interim periods (quarter and nine months). The document is non-audited and includes substantive financial data and analysis for a period shorter than a full fiscal year. This matches the definition of an Interim / Quarterly Report (IR). The document length is 15,000 characters, indicating it is the full report, not just an announcement. Therefore, the correct classification is IR with high confidence. 9M 2020
2021-03-15 English
Interim MD&A - French.pdf
Management Reports Classification · 95% confidence The document is titled 'Rapport de gestion' (Management Report) for PharmaCielo Ltd. covering the quarter and nine-month period ended September 30, 2020. It includes detailed analysis by management of financial and operational performance, references to interim unaudited consolidated financial statements, and discusses business highlights, COVID-19 impacts, and operational updates. The document is about 15,000 characters long, indicating it is a substantive report rather than a brief announcement. The content aligns with a Management Discussion and Analysis (MDA) report, which provides management's detailed explanation of financial results, business trends, and outlook for a period shorter than a full fiscal year. It is not a full Annual Report (10-K), nor a simple earnings release or regulatory filing. Therefore, the appropriate classification is Management Reports (MDA).
2021-03-15 English
Management information circular - French.PDF
AGM Information Classification · 95% confidence The document is an "Avis de convocation à l’assemblée générale annuelle et extraordinaire" (Notice of Meeting for the Annual and Extraordinary General Meeting) and a "circulaire d’information" (Information Circular) for PharmaCielo Ltd. It details the date and procedures for the AGM, including voting instructions, proxy solicitation, and agenda items such as receiving financial statements and electing directors. The document is primarily a notice and information circular related to the AGM, not the actual AGM materials or minutes. It is not a full Annual Report (10-K) or financial report but rather the meeting notice and proxy solicitation materials. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM process, including notices and circulars. The document length (15,000 characters) and content confirm it is a detailed AGM notice and circular, not just a brief announcement or a report publication announcement. Therefore, the correct classification is AGM Information (AGM-R).
2021-03-15 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release dated March 12, 2021, providing an update on PharmaCielo Ltd.'s operations in Mexico in light of legislative developments regarding recreational cannabis legalization. It discusses the company's positioning, market potential, and regulatory expectations but does not contain any financial statements, detailed financial performance data, or regulatory filings. The content is primarily an operational and strategic update rather than a formal financial report or regulatory filing. It is not an earnings release, annual or interim report, audit report, or any other formal filing type. The document is a corporate announcement about business developments and market positioning. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements and updates that do not fit other specific categories.
2021-03-12 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.